Novartis | NVS - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 364.22B 20.46B 2026-05
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Canopy Growth CAD 656.46M 124.89M 2025-12
Corcept Therapeutics USD 4.32B 654M 2026-03
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Gilead Sciences USD 167.39B 5.6B 2026-05
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
J&J USD 579.15B 78.91B 2026-03
Merck USD 297.1B 35.84B 2026-03
Novartis USD 232.75B 75B 2026-05
Pacira USD 915M 149M 2026-03
Perrigo USD 1.58B 265M 2026-05
Pfizer USD 147.4B 6.42B 2026-05
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.57B 233M 2026-05
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
Supernus Pharmaceuticals USD 2.82B 155M 2026-05
Zoetis USD 39.98B 9.73B 2026-05